Navigation Links
Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT

l is contraindicated in patients who are allergic to organic nitrates. Augmentation of the vasodilatory effects of isosorbide dinitrate by phosphodiesterase inhibitors (e.g., Viagra((R))/Revatio(TM), Levitra((R)), Cialis((R))) could result in severe hypotension.

Treatment with hydralazine may produce a clinical picture simulating systemic lupus erythematosus (SLE) including glomerulonephritis. If SLE-like symptoms occur, discontinuation of BiDil should be considered. Residua have been detected many years after discontinuation of hydralazine. Symptomatic hypotension may occur with even small doses of BiDil. BiDil should be used with caution in volume depleted or hypotensive patients. Hydralazine can cause tachycardia potentially leading to myocardial ischemia and anginal attacks. Careful clinical and hemodynamic monitoring is recommended when BiDil is administered to patients with acute myocardial infarction to avoid hypotension and tachycardia. Isosorbide dinitrate therapy may aggravate angina associated with hypertrophic cardiomyopathy.

Hydralazine hydrochloride has been associated with peripheral neuritis, evidenced by paresthesia, numbness and tingling, which may be related to an antipyridoxine effect. Caution should be exercised if BiDil is used with MAO inhibitors, alcohol, sildenafil, vardenafil or tadalafil.

Headache (50 percent) and dizziness (32 percent) were the two most frequent adverse events and were more than twice as frequent in the BiDil group.

Viagra is a registered trademark and Revatio is a trademark of Pfizer, Inc.; Levitra is a registered trademark of Bayer HealthCare, GlaxoSmithKline, and Schering-Plough; Cialis is a registered trademark of Lilly ICOS LLC.

About NitroMed, Inc.

NitroMed of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self-identified
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
2. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers Diarrhea Stimulates Immune Response Even at Low Doses
5. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals

Post Your Comments:
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)...5 ERT (Nasdaq: ERES ), ...Company,s President and CEO, and Keith Schneck, th...scheduled to present at the 21st Annual Piper Jaff...ber 1, 2009 in New York City, New York. ,, Inte...ting the Company,s corporate website at http://ww...
(Date:11/25/2009)... 25 Remedium Technologi... foam that stops severe bleeding, won first prize ...tegory of the Global Security Challenge 2009, comp...more than 100 entries from around the world, Remed...rity Summit conference held at the London School o...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Investigational Cancer Drug BSI 201 Showed Clinical Benefit in 62 25 of Patients with Triple Negative Metastatic Breast Cancer and Significantly Prolo 4530 1Investigational Cancer Drug BSI 201 Showed Clinical Benefit in 62 25 of Patients with Triple Negative Metastatic Breast Cancer and Significantly Prolo 4530 2Investigational Cancer Drug BSI 201 Showed Clinical Benefit in 62 25 of Patients with Triple Negative Metastatic Breast Cancer and Significantly Prolo 4530 3Investigational Cancer Drug BSI 201 Showed Clinical Benefit in 62 25 of Patients with Triple Negative Metastatic Breast Cancer and Significantly Prolo 4530 4Investigational Cancer Drug BSI 201 Showed Clinical Benefit in 62 25 of Patients with Triple Negative Metastatic Breast Cancer and Significantly Prolo 4530 5Stepping up minority recruiting 47791 1Stepping up minority recruiting 47791 2Stepping up minority recruiting 47791 3Recent smoking cessation research highlights importance of keeping teens from smoking 47789 1Recent smoking cessation research highlights importance of keeping teens from smoking 47789 2
... Suffer from Lower Body Injuries , , CINCINNATI, ...children are significantly more likely to have low.... The Cincinnati Children,s Hospital Medical Cente...rent body parts are injured in obese children comp...tegies can be developed, was presented May 2 at th...
...tics, LLC announces the release of its newest repo...ell Products. Despite a sluggish economy and cut... stem cell research products is expected to increa...88.9 M in 2009 and just under one billion at the e...ts are in need of a fast, accurate assessment of n...
Other Medicine Technology:The Injured Obese Child: Let's Give Him Some Ankle Support 2The Injured Obese Child: Let's Give Him Some Ankle Support 3BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available 2BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available 3
(Date:11/26/2009)... Benton Communications announces a highly effectiv...tailers struggling to make an economic recovery. ...9 -- Flu fears is the type of challenge that could...according to Dr. David Benton, business growth exp...th system – The Rfactor Intensive . &ldqu...
(Date:11/25/2009)... Nov. 25 When most peop...st. But a chiropractor can also give patients the...bular Joint, which is where your jaw (mandible) co...,, The most common symptoms associated with TMJ...pping of the jaw. But many other symptoms can be ...
(Date:11/25/2009)... Calif., Nov. 25 Onyx ...nced that the company will host two investor event...ember 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ,,...ations surrounding carfilzomib in relapsed and/or ...st American Society of Hematology (ASH) Annual Mee...
(Date:11/25/2009)... 25 /PRNewswire/ - Sentinelle Medical Inc., a lead...visualization software launches a suite of new lea...edical imaging software platform at this year,s Ra...meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth ...e high quality images generated by Sentinelle,s sp...
(Date:11/25/2009)... SPRING, Md., Nov. 25 A... FDA,s Center for Drug Evaluation and Research, ti...Safety, and the FDA," appears in the Nov. 26, 2009..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...scusses FDA efforts to strike a balance between ac...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...o researchers, smokers who eat lots of fruit and v...disease. Over 90 per cent of those with chronic ob...ex-smokers. But only one in five smokers// actuall...ersity of Southampton, UK, have carried out the fi...
...o researchers, those who consume wine in moderatio...s or those who consume other types of alcohol. It ...tion seems to confer some health benefit,// chiefl...least some of the beneficial effects. An ong...
... fact that doctors know the power of a common hear... and heart failure, many patients do not take the ...r medication after a heart attack// can reduce the... take the drugs. A new study finds there is a gap ...
...er is the most widely spread cancer all over the w...are expected to die from breast cancer this year. ...ced breastfeeding may be an important factor fueli...g and childbearing patterns. Together, the studies...
...used antidepressant may help women who suffer from...citalopram, marketed as Celexa, may help women who....// Doctors from the University of Pennsylva...ed 14 days prior to the start of menstruation. Pre...
...o a new research, a daily dose of a soybean nutrie...the "bad", or LDL, cholesterol levels in young men...nefit beyond just supplying essential nutrients. /...ytosterol to help lower cholesterol. Phytosterol i...
Other Medicine News:Health News: Breastfeeding may decrease Breast Cancer Risk 2
... long-term transtelephonic monitoring. Simple to ...gin in order to record all pre and post ECG segmen...atient sends the recorded ECG over the telephone t...immediate diagnosis. Use of Heart 2005A is recomme...
HeartView12-Lead ECG Recorder/Transmitter
... information system designed specifically to enabl... streamline their diagnostic, management, and busi...lution. Thousands of laboratory professionals from... unique "case-centric model to be effective and ea...
ABX Micros 60
Medicine Products: